APA-referens

Shitara, K., Ueha, S., Shichino, S., Aoki, H., Ogiwara, H., Nakatsura, T., . . . Doi, T. (2019). First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors. J Immunother Cancer.

Chicago-stil citat

Shitara, Kohei, et al. "First-in-human Phase 1 Study of IT1208, a Defucosylated Humanized Anti-CD4 Depleting Antibody, in Patients With Advanced Solid Tumors." J Immunother Cancer 2019.

MLA-referens

Shitara, Kohei, et al. "First-in-human Phase 1 Study of IT1208, a Defucosylated Humanized Anti-CD4 Depleting Antibody, in Patients With Advanced Solid Tumors." J Immunother Cancer 2019.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.